About Consumer Healthcare
The characteristics of consumer health products vary widely, with the two most important elements being the consumer needs they address and the strength of the claims made. The market for consumer-focused healthcare products is increasingly occupying the space between consumer needs and growing prevalence of lifestyle diseases. As consumer health companies develop a combination of consumer goods and pharmaceuticals, they have the ability to engage consumers by proving the clinical effectiveness of their products. These companies recognize unmet consumer needs and develop inventive ways to establish their presence in the marketplace.
Allergy care, dietary supplements, feminine care, pain relief, respiratory, and oral health are among the popular consumer health product categories. Some well-known products in the market are Voltaren and Panadol by GlaxoSmithKline; Lactacyd and Dermacyd by Sanofi; and Nexium, Advil, and Caltrate by Pfizer.
Technavios analysts forecast the global consumer healthcare market to grow at a CAGR of 9.26% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global consumer healthcare market for the period 2016-2020. To calculate the market size, the report considers revenue generated from the sales of OTC pharmaceuticals and dietary supplements.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavios report, Global Consumer Healthcare Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Bayer HealthCare
Boehringer Ingelheim
GlaxoSmithKline
Johnson & Johnson
Pfizer
Sanofi
Other prominent vendors
Abbott Laboratories
American Health
Amway
Arena Pharmaceuticals
BASF
BioGaia
Bukwang Pharmaceutica
Chr. Hansen
Danone
DSM
Eisai
EMS
Euradite Consumer Health and Life Care
Friggs
Genomma Lab Internacional
Glanbia
Herbalife
The Himalaya Drug Company
Kellogg
McNeil Consumer Healthcare
Mead Johnson Nutrition
Merck
Mitsubishi Tanabe Pharma
Nestlé
Novartis
Nutrition & Santé
Omega Pharma
Procter & Gamble
Reckitt Benckiser
SAVA Global
Sigma Pharmaceuticals
Sun Pharma
Taisho Pharmaceuticals
Takeda Pharmaceuticals
Teva Pharmaceuticals
Unifarma Global Consumer Healthcare
Vida Laboratories
Yakult Danone India
Market driver
Awareness about lifestyle diseases
For a full, detailed list, view our report
Market challenge
Intense competition
For a full, detailed list, view our report
Market trend
Accelerated use of online resources
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Overview: Consumer healthcare market
OTC pharmaceuticals
Dietary supplements
Key buying criteria
Factors influencing go-to-market strategy
PART 06: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 07: Market segmentation by consumer healthcare products
OTC pharmaceuticals
Dietary supplements
PART 08: Geographical segmentation
Global consumer healthcare market by geographical segmentation 2016-2020
Consumer healthcare market in Americas
Consumer healthcare market in APAC
Consumer healthcare market in EMEA
PART 09: Key leading countries
US
China
Japan
PART 10: Market drivers
Awareness about lifestyle diseases
Increase in self-medication
Growing older population
Rise in disposable income
Increase in switch from prescription to OTC products
PART 11: Impact of drivers
PART 12: Market challenges
Intense competition
Lack of valid literature
Adverse effects
Counterfeit pharmaceuticals
Stringent regulations and guidelines
PART 13: Impact of drivers and challenges
PART 14: Market trends
Accelerated use of online resources
New product launches
Promotions and marketing initiatives
Strategic alliances
PART 15: Vendor landscape
Competitive scenario
Market share 2015
PART 16: Key vendor analysis
Johnson & Johnson
Bayer HealthCare
GlaxoSmithKline
Sanofi
Pfizer
Boehringer Ingelheim
Other prominent vendors
PART 17: Appendix
List of abbreviations
PART 18: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Types of consumer healthcare products
Exhibit 03: Key regulatory bodies that approve OTC products
Exhibit 04: FDA OTC drug approval process
Exhibit 05: Mechanisms to amend OTC drug monograph
Exhibit 06: Comparison of OTC NDA versus OTC monograph process
Exhibit 07: Strategies to establish OTC pharmaceuticals in emerging markets
Exhibit 08: Recommendation of dietary supplements by health professionals
Exhibit 09: Key buying criteria in global consumer healthcare market
Exhibit 10: Factors that influence the go-to-market strategy in global consumer healthcare market
Exhibit 11: Global consumer healthcare market 2015-2020 ($ billions)
Exhibit 12: Five forces analysis
Exhibit 13: Segmentation of global consumer healthcare market by products
Exhibit 14: Global OTC pharmaceuticals market 2015-2020 ($ billions)
Exhibit 15: Global OTC pharmaceuticals market by geography 2015
Exhibit 16: Segmentation of global OTC pharmaceuticals by therapeutic class
Exhibit 17: Global OTC pharmaceuticals market segmentation by therapeutic class 2015
Exhibit 18: Drivers and challenges of global OTC pharmaceuticals market
Exhibit 19: Global dietary supplements market 2015-2020 ($ billions)
Exhibit 20: Global dietary supplements market by geography 2015
Exhibit 21: Segmentation of global dietary supplements market by product type
Exhibit 22: Global dietary supplements market by product type 2015
Exhibit 23: Drivers and challenges of global dietary supplements market
Exhibit 24: Segmentation of global consumer healthcare market by geography 2015
Exhibit 25: Global consumer healthcare market revenue by geography 2015-2020 ($ billions)
Exhibit 26: Global consumer healthcare market revenue by geography 2015-2020
Exhibit 27: Consumer healthcare market in Americas 2015-2020 ($ billions)
Exhibit 28: Consumer healthcare market in APAC 2015-2020 ($ billions)
Exhibit 29: Consumer healthcare market in EMEA 2015-2020 ($ billions)
Exhibit 30: Key leading countries in global consumer healthcare market
Exhibit 31: Drivers and challenges
Exhibit 32: Drivers and challenges
Exhibit 33: Drivers and challenges
Exhibit 34: Impact of drivers
Exhibit 35: Impact of drivers and challenges
Exhibit 36: Global internet penetration rate 2015
Exhibit 37: Johnson & Johnson: Business segmentation by revenue 2014
Exhibit 38: Johnson & Johnson: YoY growth rate and revenue of consumer healthcare segment 2012-2014 ($ billions)
Exhibit 39: Johnson & Johnson: Consumer healthcare product categories by revenue 2014
Exhibit 40: Johnson & Johnson: YOY growth rate and revenue of OTC products 2012-2014 ($ billions)
Exhibit 41: Johnson & Johnson: YoY growth rate and revenue of skin care products 2012-2014 ($ billions)
Exhibit 42: Johnson & Johnson: YoY growth rate and revenue of baby care products 2012-2014 ($ billions)
Exhibit 43: Johnson & Johnson: YoY growth rate and revenue of oral care category 2012-2014 ($ billions)
Exhibit 44: Johnson & Johnson: YoY growth rate and revenue of wound care/other products 2012-2014 ($ billions)
Exhibit 45: Johnson & Johnson: YoY growth rate and revenue of women's health products 2012-2014 ($ billions)
Exhibit 46: Johnson & Johnson: Geographical segmentation by consumer healthcare revenue 2014
Exhibit 47: Johnson & Johnson: SWOT analysis
Exhibit 48: Bayer HealthCare: Business segmentation by revenue 2014
Exhibit 49: Bayer HealthCare: Consumer health segmentation by revenue 2014
Exhibit 50: Bayer HealthCare: Geographic segmentation of consumer healthcare segment 2014
Exhibit 51: Bayer HealthCare: YoY growth rate and revenue of Contour 2012-2014 ($ millions)
Exhibit 52: Bayer HealthCare: YoY growth rate and revenue of Advantage 2012-2014 ($ millions)
Exhibit 53: Bayer HealthCare: YoY growth rate and revenue of Aspirin 2012-2014 ($ millions)
Exhibit 54: Bayer HealthCare: YoY growth rate and revenue of Aleve 2012-2014 ($ millions)
Exhibit 55: Bayer HealthCare: YoY growth rate and revenue of Bepanthen/Bepanthol 2012-2014 ($ millions)
Exhibit 56: Bayer Healthcare: SWOT analysis
Exhibit 57: GlaxoSmithKline: Business segmentation by revenue 2014
Exhibit 58: GlaxoSmithKline: YoY growth rate and revenue of consumer healthcare segment 2012-2014 ($ billions)
Exhibit 59: GlaxoSmithKline: Segmentation of consumer healthcare categories by revenue 2012-2014
Exhibit 60: GlaxoSmithKline: YoY growth rate and revenue of oral health products 2012-2014 ($ billions)
Exhibit 61: GlaxoSmithKline: YoY growth rate and revenue of wellness products 2012-2014 ($ billions)
Exhibit 62: GlaxoSmithKline: YoY growth rate and revenue of nutrition products 2012-2014 ($ millions)
Exhibit 63: GlaxoSmithKline: YoY growth rate and revenue of skin health category 2012-2014 ($ millions)
Exhibit 64: GlaxoSmithKline: Geographical segmentation by consumer health revenue 2014
Exhibit 65: GlaxoSmithKline: SWOT analysis
Exhibit 66: Sanofi: Business segmentation by revenue 2014
Exhibit 67: Sanofi: Pharmaceutical segment by revenue 2014
Exhibit 68: Sanofi: Geographical segmentation by consumer healthcare revenue 2014
Exhibit 69: Sanofi: YoY growth rate and revenue of Allegra 2012-2014 ($ millions)
Exhibit 70: Sanofi: YoY growth rate and revenue of Doliprane 2012-2014 ($ millions)
Exhibit 71: Sanofi: YoY growth rate and revenue of Essentiale 2012-2014 ($ millions)
Exhibit 72: Sanofi: YoY growth rate and revenue of Enterogermina 2012-2014 ($ millions)
Exhibit 73: Sanofi: YoY revenue comparison of Nasacort 2013 and 2014 ($ millions)
Exhibit 74: Sanofi: SWOT Analysis
Exhibit 75: Pfizer: Business segmentation by revenue 2014
Exhibit 76: Pfizer: Global vaccines, oncology, and consumer healthcare segment by revenue 2014
Exhibit 77: Pfizer: YoY growth rate and revenue of consumer healthcare category 2012-2014 ($ billions)
Exhibit 78: Pfizer: SWOT analysis
Exhibit 79: Boehringer Ingelheim: Business segmentation by revenue 2014
Exhibit 80: Boehringer Ingelheim: YoY revenue and growth rate of Buscopan 2012-2014 ($ millions)
Exhibit 81: Boehringer Ingelheim: YoY revenue and growth rate of Dulcolax 2012-2014 ($ millions)
Exhibit 82: Boehringer Ingelheim: YoY revenue and growth rate of Mucosolvan 2012-2014 ($ millions)
Exhibit 83: Boehringer Ingelheim: YoY revenue and growth rate of Pharmaton 2012-2014 ($ millions)
Exhibit 84: Boehringer Ingelheim: SWOT analysis
